Analysed NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) News Sources
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
06-08-2026
yahoo.com
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
31-08-2026
yahoo.com
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
10-09-2026
yahoo.com
NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
28-09-2026
yahoo.com
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
13-10-2026
yahoo.com
What is the current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is $2.33.
NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is $-0.13.
NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is -5.2846%.
What is the most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The most recent sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is .
SEC-8K** Filing Available For NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.